Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study.
Non-Hodgkin Lymphoma
diffuse large B cell lymphoma
follicular lymphoma
patient-reported outcomes
population-based data
quality of life
survivorship
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
30 Jul 2023
30 Jul 2023
Historique:
received:
26
06
2023
revised:
24
07
2023
accepted:
27
07
2023
medline:
12
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
To describe Health-Related Quality of Life (HRQoL) and to identify the association between sociodemographic, clinical and psychosocial factors, and self-reported HRQoL among NHL survivors. The data of the cancer registry specialized in hematological malignancies in Côte d'Or (France) were used to identify all patients diagnosed with follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) from 2010 to 2017. Patients were invited to complete SF-12 and other questionnaires. The HRQoL of NHL survivors was poorer than that of the French general population ( From 3 to 11 years post-diagnosis, the main factors found to be associated with poor HRQoL of NHL survivors were age, sex, presence of anxiety, depression and economic problems. These findings suggest the need for supportive care to improve HRQOL and the consideration of these problems when developing care plans for NHL survivors.
Identifiants
pubmed: 37568701
pii: cancers15153885
doi: 10.3390/cancers15153885
pmc: PMC10417301
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Oncologist. 2019 Nov;24(11):e1236-e1250
pubmed: 31346132
Ann Oncol. 2008 Mar;19(3):570-6
pubmed: 18056649
Oncologist. 2021 Nov;26(11):965-973
pubmed: 34327767
N Engl J Med. 1984 Dec 6;311(23):1471-5
pubmed: 6548796
Eur J Cancer Care (Engl). 2019 Jul;28(4):e13067
pubmed: 31020751
Psychooncology. 2020 Feb;29(2):364-372
pubmed: 31654534
Leuk Lymphoma. 2003 Nov;44(11):1925-9
pubmed: 14738144
Qual Life Res. 2010 Oct;19(8):1097-103
pubmed: 20443066
Cancer Res Treat. 2018 Oct;50(4):1051-1063
pubmed: 29121713
Psychooncology. 2013 Feb;22(2):241-9
pubmed: 22287503
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
J Cancer Res Clin Oncol. 2017 Dec;143(12):2469-2480
pubmed: 28831650
Oncol Nurs Forum. 2013 Mar;40(2):157-62
pubmed: 23448740
Cancer. 2009 Jul 15;115(14):3312-23
pubmed: 19452546
Ann Hematol. 2014 Sep;93(9):1531-40
pubmed: 24947794
J Clin Oncol. 2017 Jun 20;35(18):2053-2061
pubmed: 28471724
Psychol Rep. 2005 Aug;97(1):195-202
pubmed: 16279325
Nutr Cancer. 2022;74(1):158-167
pubmed: 33554640
Cancer. 2007 Apr 15;109(8):1659-67
pubmed: 17330853
Ann Hematol. 2017 May;96(5):739-747
pubmed: 28184983
Support Care Cancer. 2021 Nov;29(11):6511-6522
pubmed: 33909148
Cancers (Basel). 2017 May 20;9(5):
pubmed: 28531109
Eur J Cancer. 2015 Oct;51(15):2254-2268
pubmed: 26421827
BMC Cancer. 2015 Apr 15;15:288
pubmed: 25884669
Oncologist. 2020 Apr;25(4):e722-e732
pubmed: 32297435
Value Health. 2016 Jul-Aug;19(5):631-8
pubmed: 27565280
J Cancer Surviv. 2013 Dec;7(4):602-13
pubmed: 23918453
Cancer Treat Rep. 1977 Sep;61(6):1023-7
pubmed: 902260
J Clin Epidemiol. 1998 Nov;51(11):1171-8
pubmed: 9817135
N Engl J Med. 2012 May 24;366(21):2008-16
pubmed: 22621628
Qual Life Res. 2013 Aug;22(6):1339-51
pubmed: 22922952
Lancet. 1985 Dec 21-28;2(8469-70):1425-6
pubmed: 2867417
Transpl Int. 2017 Jan;30(1):6-10
pubmed: 27896874